What happened?
Shares of health care services provider Encompass Health (NYSE: EHC) jumped 4.7% in the morning session after the company reported third-quarter 2026 net operating revenue of $1,609.5 million and raised its full-year guidance.
According to a company press release, Encompass Health reported third-quarter net operating revenue of $1.61 billion, up 8.9% year on year, and adjusted earnings per share of $1.52. The company raised its full-year revenue guidance to $6.48 billion at the midpoint and its adjusted earnings per share outlook to $6.30 at the midpoint. Both metrics topped Wall Street expectations, with adjusted profit exceeding analyst consensus estimates by 11.9%. The boosted outlook and strong quarterly profitability reassured investors about resilient demand for inpatient rehabilitation care, helping propel shares higher in pre-market trading.
Is now the time to buy Encompass Health? Access our full analysis report here, it’s free.
What is the market telling us
Encompass Health’s shares are not very volatile and have only had 7 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 3 months ago when the stock gained 13.2% on the news that the company reported second-quarter earnings that surpassed analyst expectations for both revenue and profit.
The healthcare provider announced revenue of $1.6 billion for the quarter, an increase of 9.6% from the same period last year and 1.8% above estimates. Adjusted earnings per share (EPS) came in at $1.55, which was 4.7% higher than the consensus forecast of $1.48. The strong performance in both key financial metrics, alongside a raised full-year profit outlook, indicated healthy growth for the company, driving positive investor sentiment.
Encompass Health is up 20.9% since the beginning of the year, and at $128.63 per share, it has set a new 52-week high. Investors who bought $1,000 worth of Encompass Health’s shares 5 years ago would now be looking at an investment worth $2,024.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
